Zobrazeno 1 - 10
of 66
pro vyhledávání: '"Monir Sadat, Hakemi"'
Autor:
Sara Sadeghi, Monir Sadat Hakemi, Fatemeh Pourrezagholie, Fatemeh Naeini, Hossein Imani, Hamed Mohammadi
Publikováno v:
Trials, Vol 25, Iss 1, Pp 1-9 (2024)
Abstract Introduction Chronic kidney disease (CKD) is a pervasive disease of the current century that usually affects the adult population, especially people with diabetes and hypertension. According to the recent studies, inflammation, oxidative str
Externí odkaz:
https://doaj.org/article/f83373375b6340afbf24d12239ace986
Autor:
Asieh Mansour, Maryam Noori, Monir Sadat Hakemi, Ziba Haghgooyan, Mohammad Reza Mohajeri-Tehrani, Maryam Mirahmad, Sayed Mahmoud Sajjadi-Jazi
Publikováno v:
BMC Endocrine Disorders, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Objective One of the main features of polycystic ovary syndrome (PCOS) is increased adipose tissue, which can result in hormonal disturbances. In the present study, we aimed to investigate which indicator of obesity could better associate wi
Externí odkaz:
https://doaj.org/article/9927edd6db6d4b3aa5d1a5636755d85b
Autor:
Reza Atef Yekta, Hoda Kavosi, Pouria Esavand, Monir Sadat Hakemi, Abdolvahhab Baradaran, Zahra Tamartash
Publikováno v:
Tehran University Medical Journal, Vol 81, Iss 8, Pp 565-573 (2023)
Background: Systemic Sclerosis (SSc) is an autoimmune disease with multi-organ involvement mostly due to fibrosis and ectopic or excessive collagen fibers production in organs. Myocardial fibrosis is the main finding of cardiac involvement in patient
Externí odkaz:
https://doaj.org/article/5814768d0aee4b478d456d90f9146ad0
Autor:
Samaneh Asgari, Seyyed Saeed Moazzeni, Fereidoun Azizi, Hengameh Abdi, Davood Khalili, Monir Sadat Hakemi, Farzad Hadaegh
Publikováno v:
Global Heart, Vol 15, Iss 1 (2020)
Corrigendum In the original version of the article, the affiliation of Samaneh Asgari, Seyyed Saeed Moazzeni, Davood Khalili, and Farzad Hadaegh is not complete. The affiliation needs to be corrected to: Prevention of Metabolic Disorders Research Cen
Externí odkaz:
https://doaj.org/article/6c6a4562b9bb4c59b8b361cea3c6ad0c
Autor:
Samaneh Asgari, Seyyed Saeed Moazzeni, Fereidoun Azizi, Hengameh Abdi, Davood Khalili, Monir Sadat Hakemi, Farzad Hadaegh
Publikováno v:
Global Heart, Vol 15, Iss 1 (2020)
Background: Hypertension, with a prevalence of 25.6% is a serious public health concern in Iran. Objective: To investigate the population-based incidence of hypertension and its potential risk factors in Tehranian adults during a median follow-up of
Externí odkaz:
https://doaj.org/article/11cc292abe46476a8aff791b159da037
Autor:
Monir Sadat Hakemi, Mir Mohammad Miri, Amir Ahmad Nassiri, Reza Shahrami, Azadeh Ahmadi Koomleh, Tahereh Sabaghian
Publikováno v:
Artificial Organs
Severe forms of the coronavirus disease 2019 (COVID‐19) can progress to sepsis‐like complications accompanied by “cytokine storm” for which the most effective treatment has not yet been established. Our study describes the results of CytoSorb
Autor:
Sadaf G Sepanlou, Hamid Barahimi, Iraj Najafi, Farin Kamangar, Hossein Poustchi, Ramin Shakeri, Monir Sadat Hakemi, Akram Pourshams, Masoud Khoshnia, Abdolsamad Gharravi, Behrooz Broumand, Ali Nobakht-Haghighi, Kamyar Kalantar-Zadeh, Reza Malekzadeh
Publikováno v:
PLoS ONE, Vol 12, Iss 5, p e0176540 (2017)
BACKGROUND:The burden of chronic kidney disease (CKD) is increasing globally in particular in fast emerging economies such as Iran. Population-based studies on prevalence of CKD in Iran are scarce. The objective of the current study was to explore th
Externí odkaz:
https://doaj.org/article/077c5740c9e94b9886b71f4e5e14594d
Autor:
Manouchehr Amini, Fatemeh Yaghoubi, Marjan Akhavan, Samira Abbasloo, Farnaz Tavakoli, Azarakhsh Baghdadi, Monir Sadat Hakemi
Publikováno v:
Journal of Iranian Medical Council.
Background: While respiratory tract symptoms are the most frequent reasons for hospital admission in COVID-19 patients, renal involvement is common and is associated with worse outcomes. The aim of this study was to determine the incidence, risk fact
Publikováno v:
Nephrology Dialysis Transplantation. 37
BACKGROUND AND AIMS Proteinuria is strongly associated with the risk of CKD progression in non-diabetic and diabetic patients. SGLT2 inhibitors, as a promising new class, may provide protective effects for the kidney. Even though various studies have
Publikováno v:
Nurse and Physician within War. 8:7-15